Bladder (urinary bladder) cancer is one of the most common oncological diseases in urology and originates from the cells lining the inner surface of the bladder. While the disease may remain confined in its early stages, in some cases it can invade deeper layers of the bladder wall or spread to surrounding tissues.
Blood in the urine, burning during urination, frequent urination, and a sudden urge to urinate are among the most common symptoms of bladder cancer. Since these symptoms may also occur in other conditions, a thorough evaluation is required for an accurate diagnosis.
Diagnosis and Evaluation Process
The diagnosis of bladder cancer is based on urinalysis, imaging studies, and endoscopic examination (cystoscopy) as the main assessment tools. When necessary, tissue samples are obtained and examined pathologically to determine the type and grade of the cancer.
Based on these findings, the stage of the disease and the extent of spread are clarified. This evaluation is essential for establishing an appropriate treatment plan.
Treatment Approach
Treatment of bladder cancers is planned according to the stage of the disease, tumor characteristics, and the patient’s overall health status. In early-stage disease, intravesical therapies and surgical interventions may be prioritized, while more advanced stages may require more comprehensive treatment approaches.
The primary goals of treatment are to control the disease, reduce the risk of recurrence, and preserve bladder function as much as possible. Treatment decisions are made based on individualized evaluation.
Post-Treatment Follow-up
Because bladder cancer has a potential risk of recurrence, regular follow-up is of great importance. The course of the disease is closely monitored through endoscopic examinations, imaging studies, and clinical evaluations.
This follow-up process contributes to early detection of recurrences and achieving long-term healthy outcomes.
